Crossmark

Identification of natural product as selective PI3Kα inhibitor against NSCLC: multi-ligand pharmacophore modeling, molecular docking, ADME, DFT, and MD simulations

Crossref DOI link: https://doi.org/10.1007/s11030-023-10727-2

Published Online: 2023-09-15

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Halder, Debojyoti

Das, Subham

Jeyaprakash, R. S.
License Information

Text and Data Mining valid from 2023-09-15

Version of Record valid from 2023-09-15
More Information

Article History

Received: 3 May 2023

Accepted: 29 August 2023

First Online: 15 September 2023

Declarations

:

: The authors declare no conflict of interest in this article.

Document is current

Any future updates will be listed below